Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation

Andrew P McGovern; Michael Hogg; Beverley M Shields; Naveed A Sattar; Rury R Holman; Ewan R Pearson; Andrew T Hattersley; Angus G Jones; John M Dennis

doi:10.1136/bmjdrc-2020-001238

Article info

PDF

XML

Emerging Technologies, Pharmacology and Therapeutics

Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation

Authors

Andrew P McGovern University of Exeter Medical School, Institute of Biomedical and Clinical Science, University of Exeter, Exeter, Devon, UK PubMed articles Google scholar articles
Michael Hogg University of Exeter Medical School, Institute of Biomedical and Clinical Science, University of Exeter, Exeter, Devon, UK PubMed articles Google scholar articles
Beverley M Shields University of Exeter Medical School, Institute of Biomedical and Clinical Science, University of Exeter, Exeter, Devon, UK PubMed articles Google scholar articles
Naveed A Sattar Institute of Cardiovascular Sciences, University of Glasgow, Glasgow, UK PubMed articles Google scholar articles
Rury R Holman Radcliffe Department of Medicine, University of Oxford, Oxford, Oxfordshire, UK PubMed articles Google scholar articles
Ewan R Pearson Division of Population Health & Genomics, School of Medicine, University of Dundee, Dundee, UK PubMed articles Google scholar articles
Andrew T Hattersley University of Exeter Medical School, Institute of Biomedical and Clinical Science, University of Exeter, Exeter, Devon, UK PubMed articles Google scholar articles
Angus G Jones University of Exeter Medical School, Institute of Biomedical and Clinical Science, University of Exeter, Exeter, Devon, UK PubMed articles Google scholar articles
John M Dennis University of Exeter Medical School, Institute of Biomedical and Clinical Science, University of Exeter, Exeter, Devon, UK PubMed articles Google scholar articles
MASTERMIND consortium
Google scholar articles

Correspondence to Dr Andrew P McGovern; a.mcgovern{at}exeter.ac.uk

View Full Text

Citation

McGovern AP, Hogg M, Shields BM MASTERMIND consortium, et al

Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation

BMJ Open Diabetes Research and Care 2020;8:e001238. doi: 10.1136/bmjdrc-2020-001238

Publication history

Received January 29, 2020
Revised April 16, 2020
Accepted April 23, 2020
First published May 24, 2020.

Online issue publication

June 08, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password